|
Support : Publications : Chronolog Archives : May/June 2003 Enhancements to IMS R&D Focus on Dialog IMS R&D Focus (Files 445/955) is produced by IMS Health and provides the latest scientific and commercial developments in international pharmaceutical research and development. All aspects of a drug's development, from laboratory to international market launches, are presented in a convenient "all in one" record format, providing easy access to key drug data. Images of Drug Structures IMS R&D Focus has recently been enhanced with drug structure images. File 445 contains approximately 16,000 drug development records and approximately 5,900 of these feature images of drug structures. IMS Health expects this number to increase over time. Combined with the variations of naming available for drug compounds in IMS R&D Focus – generic names, company names, trade names and chemical names – the presence of chemical structure images provides a clear presentation of the compound in development. IMS R&D Focus joins a growing number of drug pipeline files that offer images of drug structures: Pharmaprojects (Files 128/928/PHZZ/PHAR), Prous Science Drug Data Report (File 452/ PRDR), and Prous Science Drugs of the Future (File 453/PRFU). Substance Origin A new field Substance Origin displays a description of the chemical origin of the drug. This field can be displayed only using the SO display code and appears when a document is printed out. For further information on IMS R&D Focus, consult the Dialog Bluesheet or Dialog DataStar Datasheet or contact your nearest Knowledge Center. |
IN THIS ISSUE
|
|||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||